Literature DB >> 28386355

FOXC1 promotes proliferation and epithelial-mesenchymal transition in cervical carcinoma through the PI3K-AKT signal pathway.

Liu Huang1, Zheng Huang1, Yi Fan1, Langchi He1, Ming Ye1, Kun Shi1, Bing Ji1, Jiezhen Huang1, Yibin Wang1, Qiufen Li1.   

Abstract

Recently, Forkhead box C1 (FOXC1) has been identified to play important roles in human cancers. However, the clinical significance and biological role of FOXC1 in cervical cancer remains unclear. Here, we showed that FOXC1 was frequently overexpressed in cervical cancer versus adjacent non-tumor tissues. Overexpression of FOXC1 was significantly correlated with tumor stage (P=0.011), tumor size (P=0.034), stromal invasion (P=0.001), and lymph nodes metastasis (P=0.008). Survival analysis further suggested that high FOXC1 expression was significantly correlated with poor overall survival (P=0.007) and recurrence-free survival (P=0.003) in cervical cancer patients. Moreover, we found that knock-down of FOXC1 by short hairpin RNAi significantly suppressed cervical cancer cells proliferation, migration, and invasion in vitro. Mechanistic studies showed that the FOXC1 requires PI3K/AKT signaling for its regulation of cell proliferation, migration and invasion. Our findings indicate that FOXC1 plays an important oncogenic role in cervical cancer progression.

Entities:  

Keywords:  EMT; FOXC1; cervical cancer; prognosis; progression; proliferation

Year:  2017        PMID: 28386355      PMCID: PMC5376020     

Source DB:  PubMed          Journal:  Am J Transl Res        ISSN: 1943-8141            Impact factor:   4.060


  22 in total

1.  FoxC1: Novel Regulator of Inflammation-Induced Metastasis in Hepatocellular Carcinoma.

Authors:  Rajagopal N Aravalli; Tim F Greten
Journal:  Gastroenterology       Date:  2015-08-21       Impact factor: 22.682

Review 2.  Global strategies for the treatment of early-stage and advanced cervical cancer.

Authors:  Alfonso Dueñas-González; Sergio Campbell
Journal:  Curr Opin Obstet Gynecol       Date:  2016-02       Impact factor: 1.927

Review 3.  The emerging roles of forkhead box (Fox) proteins in cancer.

Authors:  Stephen S Myatt; Eric W-F Lam
Journal:  Nat Rev Cancer       Date:  2007-11       Impact factor: 60.716

4.  Frequent Derepression of the Mesenchymal Transcription Factor Gene FOXC1 in Acute Myeloid Leukemia.

Authors:  Tim D D Somerville; Daniel H Wiseman; Gary J Spencer; Xu Huang; James T Lynch; Hui Sun Leong; Emma L Williams; Edmund Cheesman; Tim C P Somervaille
Journal:  Cancer Cell       Date:  2015-09-14       Impact factor: 31.743

Review 5.  Forkhead box proteins: tuning forks for transcriptional harmony.

Authors:  Eric W-F Lam; Jan J Brosens; Ana R Gomes; Chuay-Yeng Koo
Journal:  Nat Rev Cancer       Date:  2013-07       Impact factor: 60.716

6.  Increased expression of microRNA-196a predicts poor prognosis in human ovarian carcinoma.

Authors:  Yi Fan; Jin Fan; Liu Huang; Ming Ye; Zheng Huang; Yibin Wang; Qiufen Li; Jiezhen Huang
Journal:  Int J Clin Exp Pathol       Date:  2015-04-01

7.  FOXC1 Activates Smoothened-Independent Hedgehog Signaling in Basal-like Breast Cancer.

Authors:  Bingchen Han; Ying Qu; Yanli Jin; Yi Yu; Nan Deng; Kolja Wawrowsky; Xiao Zhang; Na Li; Shikha Bose; Qiang Wang; Sugunadevi Sakkiah; Ravinder Abrol; Tor W Jensen; Benjamin P Berman; Hisashi Tanaka; Jeffrey Johnson; Bowen Gao; Jijun Hao; Zhenqiu Liu; Ralph Buttyan; Partha S Ray; Mien-Chie Hung; Armando E Giuliano; Xiaojiang Cui
Journal:  Cell Rep       Date:  2015-11-03       Impact factor: 9.423

8.  High expression of FOXC1 is associated with poor clinical outcome in non-small cell lung cancer patients.

Authors:  Long-Xiao Wei; Run-Suo Zhou; Hai-Feng Xu; Jun-Yan Wang; Meng-Hui Yuan
Journal:  Tumour Biol       Date:  2012-12-22

9.  MicroRNA-495 downregulates FOXC1 expression to suppress cell growth and migration in endometrial cancer.

Authors:  Yan-Ying Xu; Jing Tian; Quan Hao; Li-Rong Yin
Journal:  Tumour Biol       Date:  2015-07-22

10.  Forkhead box C1 induces epithelial‑mesenchymal transition and is a potential therapeutic target in nasopharyngeal carcinoma.

Authors:  Lei Ou-Yang; Sheng-Jun Xiao; Peng Liu; Shi-Jang Yi; Xiao-Ling Zhang; Shi Ou-Yang; Sheng-Kui Tan; Xun Lei
Journal:  Mol Med Rep       Date:  2015-10-12       Impact factor: 2.952

View more
  35 in total

1.  Forkhead box C1 promotes colorectal cancer metastasis through transactivating ITGA7 and FGFR4 expression.

Authors:  Jian Liu; Zhe Zhang; Xiaowei Li; Jie Chen; Guodong Wang; Zuhong Tian; Meirui Qian; Zhangqian Chen; Hao Guo; Guangbo Tang; Wenjie Huang; Dean Tian; Daowen Wang; Yongzhan Nie; Daiming Fan; Kaichun Wu; Limin Xia
Journal:  Oncogene       Date:  2018-06-08       Impact factor: 9.867

2.  Fibroblast growth factor receptor 1 and 3 expression is associated with regulatory PI3K/AKT kinase activity, as well as invasion and prognosis, in human laryngeal cancer.

Authors:  Katarzyna Starska; Ewa Forma; Iwona Lewy-Trenda; Olga Stasikowska-Kanicka; Michał Skóra; Magdalena Bryś
Journal:  Cell Oncol (Dordr)       Date:  2018-01-03       Impact factor: 6.730

3.  Comment on "Prognostic Significance of FOXC1 in Various Cancers: A Systematic Review and Meta-Analysis".

Authors:  Bolin Wang; Yan Huang
Journal:  Mol Diagn Ther       Date:  2019-12       Impact factor: 4.074

4.  Authors' Reply to Wang and Huang: "Prognostic Significance of FOXC1 in Various Cancers: A Systematic Review and Meta-analysis".

Authors:  Rama Jayaraj; Sabapathi Nadana; Shanthi Sabarimurugan; Madhav Madurantakam Royam; Chellan Kumarasamy; Xingzhi Xu; Gaixia Xu
Journal:  Mol Diagn Ther       Date:  2019-12       Impact factor: 4.074

5.  Forkhead box protein O1 (FOXO1) and paired box gene 3 (PAX3) overexpression is associated with poor prognosis in patients with cervical cancer.

Authors:  Doo Byung Chay; Gwan Hee Han; Sanghee Nam; Hanbyoul Cho; Joon-Yong Chung; Stephen M Hewitt
Journal:  Int J Clin Oncol       Date:  2019-07-13       Impact factor: 3.402

Review 6.  Prognostic Significance of FOXC1 in Various Cancers: A Systematic Review and Meta-Analysis.

Authors:  Nadana Sabapathi; Shanthi Sabarimurugan; Madhav Madurantakam Royam; Chellan Kumarasamy; Xingzhi Xu; Gaixia Xu; Rama Jayaraj
Journal:  Mol Diagn Ther       Date:  2019-12       Impact factor: 4.074

7.  FOXC1 Negatively Regulates DKK1 Expression to Promote Gastric Cancer Cell Proliferation Through Activation of Wnt Signaling Pathway.

Authors:  Jiang Jiang; Jianfang Li; Weiwu Yao; Wenfang Wang; Bowen Shi; Fei Yuan; Jingyan Dong; Huan Zhang
Journal:  Front Cell Dev Biol       Date:  2021-04-27

8.  The role of FOXC1/FOXCUT/DANCR axis in triple negative breast cancer: a bioinformatics and experimental approach.

Authors:  Zeeba Kamaliyan; Reza Mirfakhraie; Ghasem Azizi-Tabesh; Farzaneh Darbeheshti; Ramesh Omranipour; Nasrin Ahmadinejad; Elham Zokaei; Vahid-Reza Yassaee
Journal:  Mol Biol Rep       Date:  2022-01-23       Impact factor: 2.316

9.  The Synergistic Effects of Pyrotinib Combined With Adriamycin on HER2-Positive Breast Cancer.

Authors:  Chaokun Wang; Shuzhen Deng; Jing Chen; Xiangyun Xu; Xiaochen Hu; Dejiu Kong; Gaofeng Liang; Xiang Yuan; Yuanpei Li; Xinshuai Wang
Journal:  Front Oncol       Date:  2021-05-21       Impact factor: 6.244

10.  Oncogenic role of ALX3 in cervical cancer cells through KDM2B-mediated histone demethylation of CDC25A.

Authors:  Jinhong Qi; Li Zhou; Dongqing Li; Jingyuan Yang; He Wang; Huifang Cao; Yunlan Huang; Zhiming Zhang; Linlin Chang; Chenhao Zhu; Juntong Zhan; Yong Yuan
Journal:  BMC Cancer       Date:  2021-07-16       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.